Stefoni S, Midtved K, Cole E, Thervet E, Cockfield S, Buchler M et al. Efficacy and safety outcomes among de novo renal transplant recipients managed by C2 monitoring of cyclosporine a microemulsion: results of a 12-month, randomized, multicenter study. Transplantation 2005;79(5):577-83.
Stoves J, Baker R, Newstead CG. Measurement of cyclosporin exposure in renal transplant recipients during the early post-operative period: is C2 alone sufficient? Nephrol.Dial.Transplant. 2005;20(4):854-5.
Jorga A, Holt DW, Yaqoob M, Whittaker C, Johnston A. A survey to determine the blood concentration of cyclosporine 2 hours postdose in stable renal transplant patients. Transplant Proc. 2004;36(10):3239-41.
Westley IS, Sallustio BC, Morris RG. Evaluation of the Immunotech Cyclosporine Direct Radioimmunoassay for the Determination of Whole-Blood Cyclosporine in Renal Transplant Patients. Ther.Drug Monit. 2005;27(1):90-3.
Buchler M, Johnston A. Seeking Optimal Prescription of Cyclosporine ME. Ther.Drug Monit. 2005;27(1):3-6.
Caforio AL, Tona F, Piaserico S, Gambino A, Feltrin G, Fortina AB et al. C2 is superior to C0 as predictor of renal toxicity and rejection risk profile in stable heart transplant recipients. Transpl.Int. 2005;18(1):116-24.
Stoves J, Baker R, Newstead CG. Measurement of cyclosporin exposure in renal transplant recipients during the early post-operative period: is C2 alone sufficient? Nephrol.Dial.Transplant. 2005;20(4):854-5.
Jorga A, Holt DW, Yaqoob M, Whittaker C, Johnston A. A survey to determine the blood concentration of cyclosporine 2 hours postdose in stable renal transplant patients. Transplant Proc. 2004;36(10):3239-41.
Westley IS, Sallustio BC, Morris RG. Evaluation of the Immunotech Cyclosporine Direct Radioimmunoassay for the Determination of Whole-Blood Cyclosporine in Renal Transplant Patients. Ther.Drug Monit. 2005;27(1):90-3.
Buchler M, Johnston A. Seeking Optimal Prescription of Cyclosporine ME. Ther.Drug Monit. 2005;27(1):3-6.
Caforio AL, Tona F, Piaserico S, Gambino A, Feltrin G, Fortina AB et al. C2 is superior to C0 as predictor of renal toxicity and rejection risk profile in stable heart transplant recipients. Transpl.Int. 2005;18(1):116-24.
Bioanalytics and Forensic Toxicology